IC-230 Emerging Alternatives to Human Donor Tissue for Management of Corneal Opacification | ASCRS
Session
IC-230 Emerging Alternatives to Human Donor Tissue for Management of Corneal Opacification
April 2025
Meeting: 2025 ASCRS Annual Meeting
Course Instructor: Anthony J. Aldave, MD, ABO
Co-Instructors: Sophie X. Deng, MD, PhD, ABO; Namrata Sharma, MD, FRCSEd, FRCOphth; Esen K. Akpek, MD; David S. Rootman, MD, FRCS
This content is only available to 2025 ASCRS Annual Meeting physician registrants

To log in, click the teal "Login" button in the upper right-hand corner of this page. If you are logged in but still do not have access, please check your 2025 Annual Meeting registration.

Course Description
Course will present emerging alternatives in the management of corneal opacification that are in pre-clinical studies or clinical trials. At the course conclusion, attendees will: be able to identify emerging technologies and techniques for managing loss of corneal clarity and be familiar with the advantages and disadvantages of each; and determine how, if regulatory approval is obtained, to incorporate these approaches into their practices.

Educational Objective
This course addresses a knowledge gap present in our field regarding what alternatives to donor human tissue are being developed and being investigated in preclinical and clinical trials.
2025 ASCRS Annual Meeting Instructional Courses

This 1.5 hour Instructional Course was recorded at the 2025 ASCRS Annual Meeting in Los Angeles, CA, April 25-28, 2025.